79115013 - THIOLOGICS

Information

• Trademark
• 79115013

• Source

• Serial Number

  79115013

• Registration Number

  4452854

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  January 27, 2012
  13 years ago

• Registration Date

  December 24, 2013
  11 years ago

• Transaction Date

  August 21, 2022
  2 years ago

• Status Date

  January 27, 2022
  3 years ago

• Published for Opposition Date

  October 08, 2013
  11 years ago

• Location Date

  December 24, 2013
  11 years ago

• Status Code

  404

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  TWOHIG, SHANNON MARIE

• Attorney Docket Number

  140-034

  Attorney Name

  Joel D. Voelzke

  Law Office Assigned Location Code

  L50

• Owners

  • UCL Business plc

Case File Statements

• GS0051: Pharmaceutical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; biological preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; diagnostic preparations for medical purposes; diagnostic preparations for scientific or research use; diagnostic kits consisting primarily of antibody preparations, namely, antibody bioconjugates, namely, antibody-drug conjugates, antibody-radionuclide conjugates and antibody-imaging agent conjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; diagnostic kits consisting primarily of chemical products for medical diagnostic use, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans; diagnostic kits consisting primarily of biochemical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of autoimmune, cardiovascular, central nervous system, dental, dermatology, endocrine, gastrointestinal, genetic, hematology, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncology, ophthalmological, otolaryngology, psychiatric, respiratory, urogenital, urological and viral diseases and disorders in animals and humans
• PM0000: THIO LOGICS
• GS0011: Chemicals for use in bioconjugation, reversible bioconjugation, irreversible bioconjugation, reversible cysteine protection, surface modification, and prodrug production; biochemicals, namely, polypeptides, polypeptides for in vivo applications, polypeptides for in vitro applications, polynucleic acids, polynucleic acids for in vivo applications, and polynucleic acids for in vitro applications; biomolecules, namely, proteins, peptides, antibodies, antibody fragments, antibody mimetic proteins, and polynucleic acids; chemical products for diagnostic use, namely, conjugates of polypeptides with small molecule drugs, imaging agents, and radionuclides for medical applications; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in medical research; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in diagnosis and treatment of disease
• GS0421: Scientific and technological services, namely, design and assembly of polypeptide bioconjugates and polynucleic acid bioconjugates, and design and optimization of proprietary bioconjugation technologies; biological research; chemical research and analysis; scientific advisory services relating to research and development in the field of diagnostic preparations and diagnostic products; providing scientific information and advisory services in the fields of scientific research and design, and biological and chemical research

Case File Event Statements

• 8/21/2022 - 2 years ago

  41 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED Type: DENC

• 8/21/2022 - 2 years ago

  40 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH

• 1/29/2022 - 3 years ago

  39 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT

• 12/23/2021 - 3 years ago

  38 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Type: INTS

• 12/23/2021 - 3 years ago

  37 - INVALIDATION PROCESSED Type: INPC

• 10/26/2021 - 3 years ago

  36 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR

• 10/2/2021 - 3 years ago

  35 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 2/26/2021 - 4 years ago

  34 - CANCELLED SECTION 71 Type: C71T

• 12/24/2018 - 6 years ago

  33 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3

• 6/6/2014 - 10 years ago

  32 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 5/19/2014 - 10 years ago

  31 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 5/19/2014 - 10 years ago

  30 - FINAL DISPOSITION PROCESSED Type: FIMP

• 3/24/2014 - 10 years ago

  29 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 12/24/2013 - 11 years ago

  28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 10/8/2013 - 11 years ago

  27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 10/8/2013 - 11 years ago

  26 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/7/2013 - 11 years ago

  25 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 9/18/2013 - 11 years ago

  24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 9/18/2013 - 11 years ago

  23 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 9/18/2013 - 11 years ago

  22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/30/2013 - 11 years ago

  21 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 8/22/2013 - 11 years ago

  20 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/20/2013 - 11 years ago

  19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/20/2013 - 11 years ago

  18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/20/2013 - 11 years ago

  17 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 3/7/2013 - 12 years ago

  16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 3/7/2013 - 12 years ago

  15 - FINAL REFUSAL E-MAILED Type: GNFR

• 3/7/2013 - 12 years ago

  14 - FINAL REFUSAL WRITTEN Type: CNFR

• 2/14/2013 - 12 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/14/2013 - 12 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 2/7/2013 - 12 years ago

  11 - ASSIGNED TO LIE Type: ALIE

• 2/6/2013 - 12 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/30/2012 - 12 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 8/7/2012 - 12 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 8/7/2012 - 12 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 8/7/2012 - 12 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 8/7/2012 - 12 years ago

  5 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 8/6/2012 - 12 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/3/2012 - 12 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 8/3/2012 - 12 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 8/2/2012 - 12 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR